Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
Clinical trial NCT03315754 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03315754
- Sponsor
- Steba Biotech S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-02
- Primary completion
- 2020-11-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.